Reproducibility of manual and semi-automated late enhancement quantification in patients with Fabry disease

Acta Radiologica

Volumn 55, Issue 2, 2014, Pages 155-160

  Machann, Wolfram ^a   Geier, Oliver ^b   Koeppe, Sabrina ^a   O'Donnell, Thomas ^c   Greiser, Andreas ^c   Breunig, Frank ^a   Sandstede, Joern ^a   Hahn, Dietbert ^a   Koestler, Herbert ^a,d   Beer, Meinrad ^a,d,e  

^a UNIVERSITY OF WÜRZBURG   (Germany)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c SIEMENS AG   (Germany)

^d UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

^e MEDICAL UNIVERSITY OF GRAZ   (Austria)

Author keywords

Cardiomyopathy; Late enhancement; Quantification; Reproducibility

Indexed keywords

CARDIOMYOPATHY; CONFIDENCE INTERVAL; CORRELATION COEFFICIENT; INTEROBSERVER VARIABILITY; INTRA-OBSERVER VARIABILITY; PROTOTYPE SOFTWARE; QUANTIFICATION; REPRODUCIBILITIES;

AUTOMATION; SOFTWARE PROTOTYPING;

DIAGNOSIS;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CLINICAL ARTICLE; COMPUTER PROGRAM; CORRELATION COEFFICIENT; FABRY DISEASE; HEART LEFT VENTRICLE MASS; HUMAN; IMAGE ENHANCEMENT; MALE; MANUAL LATE ENHANCEMENT IMAGING QUANTIFICATION; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE SCANNER; PRIORITY JOURNAL; REPRODUCIBILITY; SEMI AUTOMATED LATE ENHANCEMENT IMAGING QUANTIFICATION;

CARDIOMYOPATHY; LATE ENHANCEMENT; QUANTIFICATION; REPRODUCIBILITY;

ADULT; CARDIOMYOPATHIES; COHORT STUDIES; FABRY DISEASE; HEART VENTRICLES; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OBSERVER VARIATION; REPRODUCIBILITY OF RESULTS;

EID: 84896795199     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185113505275     Document Type: Article

References (25)

1. Bogaert J, Goldstein M, Tannouri F, et al. Original report. Late myocardial enhancement in hypertrophic cardiomyopathy with contrast-enhanced MR imaging. Am J Roentgenol 2003;180: 981-985.
2. Kramer CM, Barkhausen J, Flamm SD, et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008;10:35.
3. Bohl S, Wassmuth R, Abdel-Aty H, et al. Delayed enhancement cardiac magnetic resonance imaging reveals typical patterns of myocardial injury in patients with various forms of non-ischemic heart disease. Int J Cardiovasc Imaging 2008;24: 597-607.
4. Funabashi N, Toyozaki T, Matsumoto Y, et al. Images in cardiovascular medicine. Myocardial fibrosis in fabry disease demonstrated by multislice computed tomography: comparison with biopsy findings. Circulation 2003; 107: 2519-2520.
5. Moon JC, Reed E, Sheppard MN, et al. The histologic basis of late gadolinium enhancement cardiovascular magnetic resonance in hypertrophic cardiomyopathy. J Am Coll Cardiol 2004;43: 2260-2264.
6. Choudhury L, Mahrholdt H, Wagner A, et al. Myocardial scarring in asymptomatic or mildly symptomatic patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 2002;40: 2156-2164.
7. Mahrholdt H, Goedecke C, Wagner A, et al. Cardiovascular magnetic resonance assessment of human myocarditis: a comparison to histology and molecular pathology. Circulation 2004;109: 1250-1258.
8. Moon JC, McKenna WJ, McCrohon JA, et al. Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance. J Am Coll Cardiol 2003;41: 1561-1567.
9. Spiewak M, Malek LA, Chojnowska L, et al. Late gadolinium enhancement gray zone in patients with hypertrophic cardiomyopathy. Comparison of different gray zone definitions. Int J Cardiovasc Imaging 2010; 26: 693-699.
10. Bulow H, Klein C, Kuehn I, et al. Cardiac magnetic resonance imaging: long term reproducibility of the late enhancement signal in patients with chronic coronary artery disease. Heart 2005;91: 1158-1163.
11. Mahrholdt H, Wagner A, Holly TA, et al. Reproducibility of chronic infarct size measurement by contrast-enhanced magnetic resonance imaging. Circulation 2002;106: 2322-2327.
12. Amado LC, Gerber BL, Gupta SN, et al. Accurate and objective infarct sizing by contrast-enhanced magnetic resonance imaging in a canine myocardial infarction model. J Am Coll Cardiol 2004;44: 2383-2389.
13. Kolipaka A, Chatzimavroudis GP, White RD, et al. Segmentation of non-viable myocardium in delayed enhancement magnetic resonance images. Int J Cardiovasc Imaging 2005;21: 303-311.
14. Desnick RJIY, Eng CM. a -Galactosidase A deficiency: Fabry Disease. In: Scriver CRBA, Sly WS, Valle D (eds). The metabolic and molecular basis of inherited disease. 8th edn. New York, NY: McGraw-Hill, 2001.
15. Moon JC, Sheppard M, Reed E, et al. The histological basis of late gadolinium enhancement cardiovascular magnetic resonance in a patient with Anderson-Fabry disease. J Cardiovasc Magn Reson 2006;8: 479-482.
16. Moon JC, Sachdev B, Elkington AG, et al. Gadolinium enhanced cardiovascular magnetic resonance in Anderson-Fabry disease. Evidence for a disease specific abnormality of the myocardial interstitium. Eur Heart J 2003;24: 2151-2155.
17. Sandstede JJ, Pabst T, Beer M, et al. Assessment of myocardial infarction in humans with (23)Na MR imaging: comparison with cine MR imaging and delayed contrast enhancement. Radiology 2001;221: 222-228.
18. Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 1986;1: 307-310.
19. Portney LG, Watkins MP. Foundations of clinical research: Applications to practice. Upper Saddle River, NJ: Prentice Hall Inc, 2000, pp.560-567.
20. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977; 33: 159-174.
21. Hsu LY, Natanzon A, Kellman P, et al. Quantitative myocardial infarction on delayed enhancement MRI. Part I: Animal validation of an automated feature analysis and combined thresholding infarct sizing algorithm. J Magn Reson Imaging 2006;23: 298-308.
22. Maron BJ, Wolfson JK, Epstein SE, et al. Intramural ("small vessel") coronary artery disease in hypertrophic cardiomyopathy. J Am Coll Cardiol 1986;8: 545-557.
23. Varnava AM, Elliott PM, Baboonian C, et al. Hypertrophic cardiomyopathy: histopathological features of sudden death in cardiac troponin T disease. Circulation 2001;104: 1380-1384.
24. Watzinger N, Lund GK, Higgins CB, et al. The potential of contrast-enhanced magnetic resonance imaging for predicting left ventricular remodeling. J Magn Reson Imaging 2002;16: 633-640.
25. Hogan MC, Petersen SE, Hudsmith LE, et al. Effects of steady state free precession parameters on cardiac mass, function, and volumes. Int J Cardiovasc Imaging 2007;23: 583-589.